Glaxo Provides 50m Pandemic Vaccines

Anonymous User | Login

Published: 19-May-2009

In order to support governments and health authorities around the world to respond to the outbreak of global flu, British pharmaceutical giant GlaxoSmithKline has offered 50 million doses of pandemic vaccine to the World Health Organization (WHO).

The company took this step in response to an appeal made by the UN and WHO to drug makers to save some of their pandemic vaccines for poor nations. The offer was made during a meeting between the UN officials, vaccine makers and other health experts. In addition, Glaxo will reduce its pandemic vaccine prices for developing nations.

Glaxo has received orders from several countries to stockpile pandemic flu vaccine. But it will start making the vaccine as soon as it gets the vaccine’s key ingredient, a “seed stock” based on the virus.

Glaxo to make Swine-Flu Vaccine

GlaxoSmithKline (Glaxo) is planning to produce a vaccine against the current strain of the A/H1N1 virus, responsible for the outbreak of swine-flu worldwide. Glaxo is try ...

Cancer Research UK, GSK To Jointly Develop Anti-cancer Drug

Cancer Research UK and Cancer Research Technology (CRT) will commence the phase I clinical trial of GlaxoSmithKline's (GSK) anti-cancer drug 1070916A, an aurora kinase in ...

Cancer Research UK, GSK To Jointly Develop Anti-cancer Drug

Cancer Research UK and Cancer Research Technology (CRT) will commence the phase I clinical trial of GlaxoSmithKline's (GSK) anti-cancer drug 1070916A, an aurora kinase in ...

Glaxo to make Swine-Flu Vaccine

GlaxoSmithKline (Glaxo) is planning to produce a vaccine against the current strain of the A/H1N1 virus, responsible for the outbreak of swine-flu worldwide. Glaxo is try ...

US States Join Medicaid’s Lawsuits Against Wyeth

The US Justice Department has joined forces with 16 states in a legal fight against Wyeth, alleging that the drug maker has failed to reimburse hundreds of millions of do ...

Sanofi To Provide A(H1N1) Vaccine To Brazilian Government

Order provides an initial supply of 18 million doses with additional 15 million doses if required ...

Abbott Provides Full-Year Earnings Guidance For 2009

Abbott Laboratories (Abbott) announced its full-year earnings-per-share guidance for 2009 and confirmed its previously issued 2008 earnings-per-share guidance of $3.31 to ...

Abbott Reports 2008 Results

Abbott Laboratories (Abbott) has reported net sales of $7.9 billion for the full year 2008, up 10.1%, compared with the net sales of $7.2 billion in the previous year-end ...

Bristol-Myers Reports 2008 Results

Bristol-Myers Squibb Company (Bristol-Myers) has reported net sales of $20.5 billion for the full year 2008, up 13%, compared with the net sales of $18.1 billion in the p ...

Bristol-Myers Elects New President, COO

Bristol-Myers Squibb Company (Bristol-Myers), a in vitro diagnostics company, has elected Lamberto Andreotti to the company as president and chief operating officer (COO) ...

Network Sites

Contract Research Clinical Trials Contract Services Drug Delivery Drug Discovery & Development OTC Regulatory Affairs Process and Production IT and Software Laboratory Instrumentation Manufacturing Fine & Specialty Chemicals Medical Devices Business Review Inward Investment Packaging

Mail sent successfully

Tell your friend about this article

Please enter a valid email address

Please enter your name

Please enter the mail body

Your Name: *

Your Email: *

Friend's Email: *

Email Body: *: I thought you would be interested in this article : http://drugdelivery.pharmaceutical-business-review.com/news/glaxo_provides_50m_pandemic_vaccines_090519/

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

ADAPT Localization

The Translation and Localization Specialists ...

Medilingua Translations

The Medical Translation Specialists ...

Thomson Reuters

The World's Leading Source of Life Sciences Intelligent Information ...

Aveva Drug Delivery Systems

Innovative Drug Delivery Solutions ...

Capsugel

Providing Innovative Doasge Forms and Solutions to Health Care Customers ...

Tecnosoft

Monitoring Systems for Temperature, Humidity and Pressure ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Related Companies

AstraZeneca PLC

AstraZeneca PLC (AstraZeneca) is a leading pharmaceuticals company engaged in the desig ...

Schering-Plough Corporation

Schering-Plough Corporation (Schering-Plough) is a pharmaceutical company focused on di ...

Amgen Inc.

Amgen Inc. (Amgen) is a biotechnology company that is focused on the discovery, develo ...

Abbott Laboratories

Abbott Laboratories (Abbott) is a global health care company. It is principally engaged ...

GlaxoSmithKline plc

GlaxoSmithKline plc (GSK) is a is a United Kingdom-based pharmaceutical, biological, a ...

Suppliers Product News

Quality Control in Medical Translation

Various methods are available to ensure the quality of medical translations – but some are more effective than others.

Accovion Selects Liquent Insight Publisher

Contract Research Organization Chooses Thomson Reuters Software Solution

Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available

Free Access Given to Support the Global R&D and Healthcare Community

Thomson Reuters Announces the Availabilty of Three Pharma Matters Reports Covering January - March 2009

Quarterly Reports Use Market Intelligence and Competitive Analysis from Thomson Reuters to Highlight Developments in the Global Pharmaceutical Industry

Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres Tts®

Par to begin shipping clonidine TDS in the near future.

Aveva's Partner Receives FDA Approval for Onsolis

FDA approves opioid pain reliever with required risk reduction plan.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750